SciELO - Scientific Electronic Library Online

 
vol.22 número1Síndrome pulmón-riñón: serie de casos del Hospital Universitario San IgnacioEl papel de la ultrasonografía para la evaluación subclínica de la artritis reumatóide en remisión. Revisión sistemática de la literatura índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Revista Colombiana de Reumatología

versión impresa ISSN 0121-8123

Resumen

DIAZ-CORTES, Diana et al. Central nervous system involvement in systemic lupus erythematosus. Rev.Colomb.Reumatol. [online]. 2015, vol.22, n.1, pp.16-30. ISSN 0121-8123.  https://doi.org/10.1016/j.rcreu.2015.02.001.

Objectives: To review the epidemiological, pathophysiological, and neurological manifestations, as well as the diagnosis and treatment of central nervous system involvement in systemic lupus erythematosus. Methods: A literature search was performed using PubMed database complemented by review of literature references listed in identified articles. There were no limits to publication date of the literature references. Only articles in English and Spanish were included. Results: Central nervous system involvement is one of the major causes of morbidity and mortality in systemic lupus erythematosus patients. Common disorders (cumulative incidence >5%) were cerebrovascular disease and seizures, and relatively uncommon (1-5%) were severe cognitive dysfunction, acute confusional state, psychosis, while the remaining neuropsychiatric disorders were unusual (less than 1%). Mechanisms that can lead to neuropsychiatric manifestations include intracranial vascular lesions (vasculitis and thrombosis), autoantibody production against neuronal antigens, ribosomes, and phospholipids, and inflammation related to local cytokine production. Serological tests, cerebrospinal fluid, and imaging investigations have been used to support the clinical diagnosis. Treatment is based on the use of corticosteroids, immunosuppressants, and symptomatic treatment. The use of antiplatelet and antithrombotic drugs was indicated when positive moderate-to-high titres of anti-phospholipid antibodies were present. Conclusions: The involvement of vital organs and tissues, such as the brain, in patients with systemic lupus erythematosus, impels efforts to develop diagnostic tools for systemic lupus erythematosus associated neuropsychiatric disease to guide effective therapeutic decisions. © 2014 Asociación Colombiana de Reumatología. Published by Elsevier España, S.L.U

Palabras clave : Systemic lupus erythematosus Vasculitis; Seizures; Morbidity; Mortality.

        · resumen en Español     · texto en Español     · Español ( pdf )